Danish Angle Closure Prevention Trial

Recruiting now · Not applicable

Conditions studied: Primary Angle Glaucoma Closure Suspect

In brief

To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.

Key facts

Study ID

NCT06077253

Run by

University of Aarhus

People needed

242

Starts

2023-09-01

Expected to finish

2029-09-01

Last updated by the study team

2023-11-13

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary angle closure suspect: ≥180 degrees (cumulative) irido-trabecular contact on darkroom gonioscopy, IOP<21mmHg, no peripheral anterior synechiae, no glaucomatous optic neuropathy
• Best-corrected visual acuity (BCVA) >0.8 on both eyes
• Caucasian

You may not qualify if…

• Pseudophakia
• Previous iridotomy
• Clinically significant cataract with indication for surgery,
• Gaucoma
• Uveitis
• Unstable retinal conditions
• Ocular malignancies
• PEX
• PDS
• Systemic or ocular corticosteroid treatment

Where it is running

• Aalborg University Hospital — Aalborg, Denmark (enrolling)
• Aarhus University Hospital — Aarhus, Denmark (enrolling)
• Rigshospitalet Glostrup — Glostrup Municipality, Denmark (enrolling)
• Sygehus Lillebælt — Vejle, Denmark (enrolling)
• Odense University Hospital — Odense, Denmark

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.